SlideShare ist ein Scribd-Unternehmen logo
1 von 27
Downloaden Sie, um offline zu lesen
Risk-Based Approaches in GMP’s Project
Life Cycles



Jorge A. Cordero-Monroig; BSChE, MBA-GM
Sr. Equipment/Control System Validation Engineer
B+L Greenville Solutions Plant




                                          CONFIDENTIAL   [1]
Risk-Based Approaches in GMP’s Project Life Cycles

Agenda:


   How to identify a GMP Project
   Why Risk-based Approach
   GMP Project Life Cycle – The Structure
   GMP Project Life Cycle – The Implementation
   Interactive Exercise: GMP Project Life Cycle – The Application
   Q&A




                                                                     [2]
Risk-Based Approaches in GMP’s Project Life Cycles

How to identify a GMP Project:
    GMP (Good Manufacturing Practices) - GMP is a group of practices
     used to ensure that a product is consistently manufactured within quality
     standards. In other words, practices that guarantee the strength-potency,
     purity, quality, identity and safety of the product.
    What is a GMP Project – Any project that affect any equipment, control
     system, software, process or facility (ECS-SPF) that have direct impact in
     the safety, identity, potency-strength, quality and/or purity of the product.
        For example:
             Equipments: Mix Tanks (Reactors)
             Control Systems: DCS (Distribute Control System)
             Software: Blue Mountain (Calibration/Metrology Software)
             Process: Product Compounding // Cleaning // Chemistry final
              product test.
             Facility: Clean Rooms (Class A / 100 / ISO 5) renovations



                                                                                     [3]
Risk-Based Approaches in GMP’s Project Life Cycles

How to identify a GMP Project (Cont.):
   The first step to identify a GMP project is listing all the
    equipment, control system, software, process or facility
    (ECS-SPF) affected by the project.
   After break down all the equipment, control system,
    software, process or facility (ECS-SPF) related with the
    project, we need to perform an impact assessment for
    each one.
   Impact Assessment Classifications:
     Direct Impact
     Indirect Impact
     No Impact

                                                                  [4]
Risk-Based Approaches in GMP’s Project Life Cycles

How to identify a GMP Project (Cont.):
   Direct Impact (ECS-SPF) shall answer YES to one of the
    following questions:
     Does the ECS-SPF come in direct physical contact with the
      product?
        Example: Filler, Tanks, Pumps, Agitators, etc…

     Does the ECS-SPF produce or distribute a material that has direct
      contact with product?
        Example: Bottles/Caps Molding machines, Form Fill & Seal
         (FFS) Machines, etc…

     Is the ECS-SPF used for cleaning, sanitize or sterilize?
         Example: SIP and CIP systems, Autoclaves, etc…

                                                                          [5]
Risk-Based Approaches in GMP’s Project Life Cycles

How to identify a GMP Project (Cont.):
    Does the ECS-SPF create or maintain a specified environmental
     condition required to preserve product quality?
       Example: HVAC, Class A / ISO 5 rooms, etc…

    Does the ECS-SPF produce, monitor, evaluate, store or report
     data used to accept or reject product or GMP materials or data
     used to support Regulatory Compliance-Practices?
       Example: DCS, E-Batch Records, EMS, etc…

    Does the ECS-SPF perform a critical process step or operation in
     the manufacturing, processing, packaging, labeling testing or
     holding of the product?
        Example: Inspections Systems, Process Filters, scales, etc…


                                                                        [6]
Risk-Based Approaches in GMP’s Project Life Cycles

How to identify a GMP Project (Cont.):
   Indirect Impacts ECS-SPF shall answer YES to the
    following question:
     Is the ECS-SPF linked or support a direct impact systems?
         Example: DI Water Systems, Chillers, Compressed Air Units,
          etc…


   No Impact ECS-SPF answer NO to all previous questions.
         Example: Cooling Towers, Sand Filters, Office HVAC Units,
          OEE Systems, etc…
   No impact ECS-SPF are not critical for the product quality
    but could be critical for business purpose.


                                                                       [7]
Risk-Based Approaches in GMP’s Project Life Cycles

How to identify a GMP Project (Cont.):
   After classify the impact for the ECS-SPF projects, it is
    important determine the risk level for the Direct Impact.
    Indirect impact can be included in the risk analysis based on
    the impact on business.
   Risk Assessments Categories:
     High
     Medium
     Low
   The purpose of the risk assessment classification is to focus on
    issues that impact the patient safety, product quality and data
    integrity on the early stages of the process.



                                                                       [8]
Risk-Based Approaches in GMP’s Project Life Cycles

Why Risk-based Approach
   What are the benefits of Risk-Based Approach?
     Identify and evaluate every single component, system, or
      unit of the project.
     Classify each component, system, or unit of the project as
      Direct, Indirect or No Impact.
     Justify decisions made based on risk criticality.
     Identify areas that will require more evaluation, adjustments,
      or re-design prior to the implementation.
     Provide a solid rational of the project plan, schedule, and
      project due date.
     Put more effort in the design stage of the process but
      minimize the qualification effort which means less down
      time.
                                                                       [9]
Risk-Based Approaches in GMP’s Project Life Cycles

Why Risk-based Approach
   What are the requirements of Risk-Based Approach?
     Determine the overall impact of the project in the patient
      safety, product quality, and data integrity
     Analyze the risk to the business
     Identify risk to specific process
     Identify risk to specific functions
     Design to eliminate risk
     Define controls to mitigate risk that cannot be eliminated
     Define validation strategy
     Revise the risk assessments as require during the project
      life.


                                                                   [ 10 ]
Risk-Based Approaches in GMP’s Project Life Cycles

Why Risk-based Approach
   Most Common Risk Assessments Models:
    FMEA (Failure Modes & Effects Analysis)
    FTA (Fault Tree Analysis)
    HAZOP (Hazard Operability Analysis)
    Risk Priority
    Etc…




                                                     [ 11 ]
Why Risk-based Approach
   Risk Priority:




                          [ 12 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Structure
   Project Phase Life Cycle :
     Project Origination
     Project Initiation
     Project Planning and Design
     Project Execution and Control
     Project Close-out




                                                     [ 13 ]
Risk-Based Approaches in GMP’s Project Life Cycles
GMP Project Life Cycle – The Structure
   Task and Responsibilities
      Project Origination
         Project identification: Process Owner (PO), Quality Assurance
          (QA), or Process Excellence (PEx) based on business, and/or
          regulation needs
         Project evaluation: By process excellence team
         Project selection: By upper management
     Project Initiation
        Project team development: Project Manager (PM)
        Project definition: Project Manager, Project Engineer (PE), PO, QA,
          Procurement
         Initial risk identification: PEx, PO and QA
         Project plan: PM
         Project Plan Approval: Project team members
                                                                               [ 14 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Structure
   Task and Responsibilities
     Project Planning and Design
       Project meeting and expectations: Team Members
       Refine project Definition:
           – Scope: PE and PO
           – Schedule: PM and PE
           – Quality Standards: QA
           – Budget: PM, PE, and Procurement
       Approve Project Plan
       Vendor Selection and PO approval: PE and
         Procurement
       Design Verification and approval: PE, PO, and QA
                                                           [ 15 ]
ASC

GMP Project Life Cycle – The Structure
   Task and Responsibilities
     Project Execution and Control
       Equipment, control system, software, process or facility
         (ECS-SPF) development verification: PE, PO, and QA
       Installation and Operational verification: PE and QA
       Calibration, procedures, and preventive maintenance
         implementation: PM and PO
     Project Close-out
       Implementation verification: PM and PE
       Risk Assessment Review: PEx, PO and QA
       Close-out Letter: PM


                                                                   [ 16 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Structure
   Tools:
     Project Origination:
         Project Proposal,
         Evaluation Rating Matrix
     Project Initiation:
         Project Charter
         Proposed Schedule
         Impact Assessment (GMP or Not GMP)
         User Requirement Specification
         Project Plan (Project Strategy)
         Budget Estimate
         Initial Risk Assessment (High/Medium/Low Risk)

                                                           [ 17 ]
Risk-Based Approaches in GMP’s Project Life Cycles
GMP Project Life Cycle – The Structure
   Tools:
     Project Planning and Design:
        Functional Requirement Specifications
        Functional Risk Assessment
        Traceability Matrix
        Revised Schedule
        Revised Budget
        Validation Strategy
        Design Specification/Qualification (DS/DQ)
     Project Execution and Control
        Factory Acceptance Test (FAT)
        Commissioning / Site Acceptance Test (SAT) / Engineering Studies
        Risk Assessment Review
        Qualification / Validation Protocols
        SOP’s, PM’s, and Calibration Program
     Project Close-out
        Traceability Matrix Review
        Closing Letter

                                                                            [ 18 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Structure
   Phases Approach:
     After completion of each phase a formal Phase Review Report
      should be evaluated and approved by the Project Team Members.
     Phase criteria should be completed before move to the next
      phase.
     Incomplete criteria shall be justified on the Phase Review Report.
     Benefits of Phases Approach:
         Ensure that there is no missing elements during each phase.
         Force the team members to evaluate the project goals and
          expectations constantly.
         Keep control of the project




                                                                           [ 19 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Structure
   How to measure Success
     Align schedule with Phase Review Reports deliverables
     Project design mitigate, control, and measure the identified
      risks
     User requirements, functional requirements, and design
      specs were addressed and tested satisfactorily on FAT,
      SAT, IQ, OQ, PQ, or PV.
     IOPQ and PV have been executed satisfactorily and
      approved.
     Project has been implemented and closed as scheduled.
     Project cost are within the budget requested.



                                                                     [ 20 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Implementation
   Who, How, and When:
    – Change Control:
       • Who: PM, PE, or PO
       • How: Any project that affect a GMP equipment, control system,
         software, process or facility shall be managed under local change
         control process.
       • When: Before start with the project execution and control phase.
    – Schedule and Timing:
       • Who: PM and PE
       • How: Progress report and meeting should be implemented to
         manage the schedule and keep visibility of the project progress.
         Milestone shall be identified and addressed.
       • When: Across the entire project, typically weekly.



                                                                             [ 21 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Implementation
   Who, How, and When:
    – Protocols and Verifications:
        • Who: Vendor, Consultant, Operation personnel, PE, or QA-Validation
        • How:
           – FAT and SAT shall be reviewed an approved by quality in order
             to be leverage on the IQ, OQ, and PQ. As specified on
             Validation Strategy.
           – FAT and SAT shall cover all details, configurations,
             functionalities, and safety requirements.
           – Limited IQ, OQ, and PQ can be performed based on FAT and
             SAT successful test. PV, as applicable, to demonstrate that the
             process is suitable for intended use (process is validated).
        • When:
           – FAT is performed at vendor facility. SAT performed at the site.
           – Qualifications / Validation: After success FAT and SAT.
                                                                               [ 22 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Implementation
   Who, How, and When:
    – SOP’s and Preventive Maintenance:
       • Who: PO, PE, and/ or Plant Engineer
       • How:
          – Update and/or create standard operational procedure and
            preventive maintenance task, and include any critical
            instrumentation to the calibration process.
          – Include the changes in the Change control plan
       • When:
          – Update and development (draft) before the operational
            qualification.
          – Approved for the Performance qualification
          – Effectives after qualification/validation completion but before start
            the normal operation.


                                                                                    [ 23 ]
Risk-Based Approaches in GMP’s Project Life Cycles

GMP Project Life Cycle – The Implementation
   Who, How, and When:
    – Traceability Matrix, Risk Assessment Review and Closing Letter:
       • Who: PM, or PE
       • How:
          – Using a matrix verify that all critical requirement in URS, FRS,
            and DS, as applicable, were tested in one of the deliverables.
          – Reviewing the Risk Assessment to confirm that the risk were
            mitigated or controlled.
          – Write a memo or project plan final report summarizing the
            activities performance and completion.
       • When:
          – After approval of all qualification protocols final reports.




                                                                               [ 24 ]
Risk-Based Approaches in GMP’s Project Life Cycles

Interactive Exercise: GMP Project Life Cycle – The
   Application
   Determine if the project is GMP or not GMP (Direct/Indirect/No
    Impact)
   Outline a Project Life cycle
   Perform a Risk Assessment
   Manage Constraints


   Projects:
     –   Sampling Booth in a Warehouse
     –   Metrology Software
     –   Mix Tank (Reactor)
     –   Compressed Air


                                                                     [ 25 ]
Risk-Based Approaches in GMP’s Project Life Cycles

Bonus Material
   Risk Based Approach Project Life Cycle Phase Matrix
   Phase Review Report Template




                                                          [ 26 ]
Risk-Based Approaches in GMP’s Project Life Cycles




        Questions and Answers

                            ?

                                                     [ 27 ]

Weitere ähnliche Inhalte

Was ist angesagt?

01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentation01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentationKathey Bacigalupo
 
ISO: 14971 Quality risk management of medical devices
ISO: 14971 Quality risk management  of medical devicesISO: 14971 Quality risk management  of medical devices
ISO: 14971 Quality risk management of medical devicesAtul Bhombe
 
CCP and CQA concept .pdf
CCP and CQA concept .pdfCCP and CQA concept .pdf
CCP and CQA concept .pdfTummaRamarao1
 
Sequence and interaction of qms processes
Sequence and interaction of qms processesSequence and interaction of qms processes
Sequence and interaction of qms processesJorge Torres
 
Batch release certificate for medical device
Batch release certificate for medical deviceBatch release certificate for medical device
Batch release certificate for medical deviceMalesh M
 
Summarized presentation VDA 6.3 2016 (development)
Summarized presentation VDA 6.3 2016 (development)Summarized presentation VDA 6.3 2016 (development)
Summarized presentation VDA 6.3 2016 (development)Kiran Walimbe
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Managementmuna_ali
 
Risk 1 actual test 7 (273 q)
Risk 1 actual test 7 (273 q)Risk 1 actual test 7 (273 q)
Risk 1 actual test 7 (273 q)Mohamed Saeed
 

Was ist angesagt? (11)

01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentation01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentation
 
FDA GMP Training - The Quality Audit
FDA GMP Training - The Quality AuditFDA GMP Training - The Quality Audit
FDA GMP Training - The Quality Audit
 
ISO: 14971 Quality risk management of medical devices
ISO: 14971 Quality risk management  of medical devicesISO: 14971 Quality risk management  of medical devices
ISO: 14971 Quality risk management of medical devices
 
Presentation on QRM_NS
Presentation on QRM_NSPresentation on QRM_NS
Presentation on QRM_NS
 
CCP and CQA concept .pdf
CCP and CQA concept .pdfCCP and CQA concept .pdf
CCP and CQA concept .pdf
 
Sequence and interaction of qms processes
Sequence and interaction of qms processesSequence and interaction of qms processes
Sequence and interaction of qms processes
 
Batch release certificate for medical device
Batch release certificate for medical deviceBatch release certificate for medical device
Batch release certificate for medical device
 
Summarized presentation VDA 6.3 2016 (development)
Summarized presentation VDA 6.3 2016 (development)Summarized presentation VDA 6.3 2016 (development)
Summarized presentation VDA 6.3 2016 (development)
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
 
Risk 1 actual test 7 (273 q)
Risk 1 actual test 7 (273 q)Risk 1 actual test 7 (273 q)
Risk 1 actual test 7 (273 q)
 
Good Distribution Practices
Good Distribution PracticesGood Distribution Practices
Good Distribution Practices
 

Ähnlich wie Risk-Based Approaches in GMP’s Project Life Cycles

Quality by Design Course Preview
Quality by Design Course PreviewQuality by Design Course Preview
Quality by Design Course PreviewInvensis Learning
 
Project risk management overview
Project risk management overviewProject risk management overview
Project risk management overviewShereef Sabri
 
Module-4 PART-2&3.ppt
Module-4 PART-2&3.pptModule-4 PART-2&3.ppt
Module-4 PART-2&3.pptSharatNaik11
 
Risk based conceptual design delivery
Risk based conceptual design deliveryRisk based conceptual design delivery
Risk based conceptual design deliveryNNE
 
Project Management Cycle and MS Project 2013 By Subodh Kumar PMP
Project Management Cycle and  MS Project 2013  By Subodh Kumar PMPProject Management Cycle and  MS Project 2013  By Subodh Kumar PMP
Project Management Cycle and MS Project 2013 By Subodh Kumar PMPSubodh Kumar
 
SW Development Methodologies
SW Development MethodologiesSW Development Methodologies
SW Development Methodologiesthiago_tadeu
 
Unit 1 basic concepts of testing & quality
Unit 1   basic concepts of testing & qualityUnit 1   basic concepts of testing & quality
Unit 1 basic concepts of testing & qualityravikhimani1984
 
Unit 1 basic concepts of testing & quality
Unit 1   basic concepts of testing & qualityUnit 1   basic concepts of testing & quality
Unit 1 basic concepts of testing & qualityravikhimani
 
42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdf
42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdf42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdf
42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdfNanoSana
 
Risk Driven Testing
Risk Driven TestingRisk Driven Testing
Risk Driven TestingJorge Boria
 
16103271 software-testing-ppt
16103271 software-testing-ppt16103271 software-testing-ppt
16103271 software-testing-pptatish90
 
30.11.2011 Best practice mining risk management cradle to grave, John Wheadon
30.11.2011 Best practice mining risk management cradle to grave, John Wheadon30.11.2011 Best practice mining risk management cradle to grave, John Wheadon
30.11.2011 Best practice mining risk management cradle to grave, John WheadonThe Business Council of Mongolia
 
PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...
PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...
PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...ijseajournal
 

Ähnlich wie Risk-Based Approaches in GMP’s Project Life Cycles (20)

CTFL chapter 05
CTFL chapter 05CTFL chapter 05
CTFL chapter 05
 
Quality by Design Course Preview
Quality by Design Course PreviewQuality by Design Course Preview
Quality by Design Course Preview
 
Project risk management overview
Project risk management overviewProject risk management overview
Project risk management overview
 
Introduction to Software Quality & its' Challenges
Introduction to Software Quality & its' ChallengesIntroduction to Software Quality & its' Challenges
Introduction to Software Quality & its' Challenges
 
Module-4 PART-2&3.ppt
Module-4 PART-2&3.pptModule-4 PART-2&3.ppt
Module-4 PART-2&3.ppt
 
Risk based conceptual design delivery
Risk based conceptual design deliveryRisk based conceptual design delivery
Risk based conceptual design delivery
 
Testing throughout
Testing throughoutTesting throughout
Testing throughout
 
Project Management Cycle and MS Project 2013 By Subodh Kumar PMP
Project Management Cycle and  MS Project 2013  By Subodh Kumar PMPProject Management Cycle and  MS Project 2013  By Subodh Kumar PMP
Project Management Cycle and MS Project 2013 By Subodh Kumar PMP
 
CTFL Module 01
CTFL Module 01CTFL Module 01
CTFL Module 01
 
SW Development Methodologies
SW Development MethodologiesSW Development Methodologies
SW Development Methodologies
 
Test Life Cycle
Test Life CycleTest Life Cycle
Test Life Cycle
 
CRO - Clinical Vendor Oversight Webinar.
CRO - Clinical Vendor Oversight Webinar.CRO - Clinical Vendor Oversight Webinar.
CRO - Clinical Vendor Oversight Webinar.
 
Unit 1 basic concepts of testing & quality
Unit 1   basic concepts of testing & qualityUnit 1   basic concepts of testing & quality
Unit 1 basic concepts of testing & quality
 
Unit 1 basic concepts of testing & quality
Unit 1   basic concepts of testing & qualityUnit 1   basic concepts of testing & quality
Unit 1 basic concepts of testing & quality
 
42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdf
42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdf42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdf
42da6c0a8a35bb6c9e0bbb89ad429678_MIT1_040s09_lec01.pdf
 
Risk Driven Testing
Risk Driven TestingRisk Driven Testing
Risk Driven Testing
 
Risk Management
Risk ManagementRisk Management
Risk Management
 
16103271 software-testing-ppt
16103271 software-testing-ppt16103271 software-testing-ppt
16103271 software-testing-ppt
 
30.11.2011 Best practice mining risk management cradle to grave, John Wheadon
30.11.2011 Best practice mining risk management cradle to grave, John Wheadon30.11.2011 Best practice mining risk management cradle to grave, John Wheadon
30.11.2011 Best practice mining risk management cradle to grave, John Wheadon
 
PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...
PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...
PRODUCT QUALITY EVALUATION METHOD (PQEM): TO UNDERSTAND THE EVOLUTION OF QUAL...
 

Mehr von Institute of Validation Technology

Incorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP AuditingIncorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP AuditingInstitute of Validation Technology
 
Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Institute of Validation Technology
 
Computer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudComputer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudInstitute of Validation Technology
 
Management Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality ImprovementManagement Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality ImprovementInstitute of Validation Technology
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Institute of Validation Technology
 
Designing Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentDesigning Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentInstitute of Validation Technology
 
Incorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation PlanIncorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation PlanInstitute of Validation Technology
 
Introduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationIntroduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationInstitute of Validation Technology
 
GMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance ToolGMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance ToolInstitute of Validation Technology
 

Mehr von Institute of Validation Technology (20)

Incorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP AuditingIncorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP Auditing
 
Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...
 
Lifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning ValidationLifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning Validation
 
Computer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudComputer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the Cloud
 
Applying QbD to Biotech Process Validation
Applying QbD to Biotech Process ValidationApplying QbD to Biotech Process Validation
Applying QbD to Biotech Process Validation
 
Management Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality ImprovementManagement Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality Improvement
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
 
Effective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data TrendingEffective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data Trending
 
Mock Inspection Case Studies
Mock Inspection Case StudiesMock Inspection Case Studies
Mock Inspection Case Studies
 
Validation Master Plan
Validation Master PlanValidation Master Plan
Validation Master Plan
 
Designing Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentDesigning Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical Development
 
Determine Exceptions to Validation
Determine Exceptions to ValidationDetermine Exceptions to Validation
Determine Exceptions to Validation
 
Conduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation ProgrammeConduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation Programme
 
FDA Inspection
FDA InspectionFDA Inspection
FDA Inspection
 
Incorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation PlanIncorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation Plan
 
Compliance by Design and Compliance Master Plan
Compliance by Design and Compliance Master PlanCompliance by Design and Compliance Master Plan
Compliance by Design and Compliance Master Plan
 
Introduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationIntroduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process Validation
 
GMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance ToolGMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance Tool
 
A Lifecycle Approach to Process Validation
A Lifecycle Approach to Process ValidationA Lifecycle Approach to Process Validation
A Lifecycle Approach to Process Validation
 
Setting Biological Process Specifications
Setting Biological Process SpecificationsSetting Biological Process Specifications
Setting Biological Process Specifications
 

Kürzlich hochgeladen

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 

Kürzlich hochgeladen (20)

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 

Risk-Based Approaches in GMP’s Project Life Cycles

  • 1. Risk-Based Approaches in GMP’s Project Life Cycles Jorge A. Cordero-Monroig; BSChE, MBA-GM Sr. Equipment/Control System Validation Engineer B+L Greenville Solutions Plant CONFIDENTIAL [1]
  • 2. Risk-Based Approaches in GMP’s Project Life Cycles Agenda:  How to identify a GMP Project  Why Risk-based Approach  GMP Project Life Cycle – The Structure  GMP Project Life Cycle – The Implementation  Interactive Exercise: GMP Project Life Cycle – The Application  Q&A [2]
  • 3. Risk-Based Approaches in GMP’s Project Life Cycles How to identify a GMP Project:  GMP (Good Manufacturing Practices) - GMP is a group of practices used to ensure that a product is consistently manufactured within quality standards. In other words, practices that guarantee the strength-potency, purity, quality, identity and safety of the product.  What is a GMP Project – Any project that affect any equipment, control system, software, process or facility (ECS-SPF) that have direct impact in the safety, identity, potency-strength, quality and/or purity of the product.  For example:  Equipments: Mix Tanks (Reactors)  Control Systems: DCS (Distribute Control System)  Software: Blue Mountain (Calibration/Metrology Software)  Process: Product Compounding // Cleaning // Chemistry final product test.  Facility: Clean Rooms (Class A / 100 / ISO 5) renovations [3]
  • 4. Risk-Based Approaches in GMP’s Project Life Cycles How to identify a GMP Project (Cont.):  The first step to identify a GMP project is listing all the equipment, control system, software, process or facility (ECS-SPF) affected by the project.  After break down all the equipment, control system, software, process or facility (ECS-SPF) related with the project, we need to perform an impact assessment for each one.  Impact Assessment Classifications:  Direct Impact  Indirect Impact  No Impact [4]
  • 5. Risk-Based Approaches in GMP’s Project Life Cycles How to identify a GMP Project (Cont.):  Direct Impact (ECS-SPF) shall answer YES to one of the following questions:  Does the ECS-SPF come in direct physical contact with the product?  Example: Filler, Tanks, Pumps, Agitators, etc…  Does the ECS-SPF produce or distribute a material that has direct contact with product?  Example: Bottles/Caps Molding machines, Form Fill & Seal (FFS) Machines, etc…  Is the ECS-SPF used for cleaning, sanitize or sterilize?  Example: SIP and CIP systems, Autoclaves, etc… [5]
  • 6. Risk-Based Approaches in GMP’s Project Life Cycles How to identify a GMP Project (Cont.):  Does the ECS-SPF create or maintain a specified environmental condition required to preserve product quality?  Example: HVAC, Class A / ISO 5 rooms, etc…  Does the ECS-SPF produce, monitor, evaluate, store or report data used to accept or reject product or GMP materials or data used to support Regulatory Compliance-Practices?  Example: DCS, E-Batch Records, EMS, etc…  Does the ECS-SPF perform a critical process step or operation in the manufacturing, processing, packaging, labeling testing or holding of the product?  Example: Inspections Systems, Process Filters, scales, etc… [6]
  • 7. Risk-Based Approaches in GMP’s Project Life Cycles How to identify a GMP Project (Cont.):  Indirect Impacts ECS-SPF shall answer YES to the following question:  Is the ECS-SPF linked or support a direct impact systems?  Example: DI Water Systems, Chillers, Compressed Air Units, etc…  No Impact ECS-SPF answer NO to all previous questions.  Example: Cooling Towers, Sand Filters, Office HVAC Units, OEE Systems, etc…  No impact ECS-SPF are not critical for the product quality but could be critical for business purpose. [7]
  • 8. Risk-Based Approaches in GMP’s Project Life Cycles How to identify a GMP Project (Cont.):  After classify the impact for the ECS-SPF projects, it is important determine the risk level for the Direct Impact. Indirect impact can be included in the risk analysis based on the impact on business.  Risk Assessments Categories:  High  Medium  Low  The purpose of the risk assessment classification is to focus on issues that impact the patient safety, product quality and data integrity on the early stages of the process. [8]
  • 9. Risk-Based Approaches in GMP’s Project Life Cycles Why Risk-based Approach  What are the benefits of Risk-Based Approach?  Identify and evaluate every single component, system, or unit of the project.  Classify each component, system, or unit of the project as Direct, Indirect or No Impact.  Justify decisions made based on risk criticality.  Identify areas that will require more evaluation, adjustments, or re-design prior to the implementation.  Provide a solid rational of the project plan, schedule, and project due date.  Put more effort in the design stage of the process but minimize the qualification effort which means less down time. [9]
  • 10. Risk-Based Approaches in GMP’s Project Life Cycles Why Risk-based Approach  What are the requirements of Risk-Based Approach?  Determine the overall impact of the project in the patient safety, product quality, and data integrity  Analyze the risk to the business  Identify risk to specific process  Identify risk to specific functions  Design to eliminate risk  Define controls to mitigate risk that cannot be eliminated  Define validation strategy  Revise the risk assessments as require during the project life. [ 10 ]
  • 11. Risk-Based Approaches in GMP’s Project Life Cycles Why Risk-based Approach  Most Common Risk Assessments Models: FMEA (Failure Modes & Effects Analysis) FTA (Fault Tree Analysis) HAZOP (Hazard Operability Analysis) Risk Priority Etc… [ 11 ]
  • 12. Why Risk-based Approach  Risk Priority: [ 12 ]
  • 13. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Structure  Project Phase Life Cycle :  Project Origination  Project Initiation  Project Planning and Design  Project Execution and Control  Project Close-out [ 13 ]
  • 14. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Structure  Task and Responsibilities  Project Origination  Project identification: Process Owner (PO), Quality Assurance (QA), or Process Excellence (PEx) based on business, and/or regulation needs  Project evaluation: By process excellence team  Project selection: By upper management  Project Initiation  Project team development: Project Manager (PM)  Project definition: Project Manager, Project Engineer (PE), PO, QA, Procurement  Initial risk identification: PEx, PO and QA  Project plan: PM  Project Plan Approval: Project team members [ 14 ]
  • 15. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Structure  Task and Responsibilities  Project Planning and Design Project meeting and expectations: Team Members Refine project Definition: – Scope: PE and PO – Schedule: PM and PE – Quality Standards: QA – Budget: PM, PE, and Procurement Approve Project Plan Vendor Selection and PO approval: PE and Procurement Design Verification and approval: PE, PO, and QA [ 15 ]
  • 16. ASC GMP Project Life Cycle – The Structure  Task and Responsibilities  Project Execution and Control Equipment, control system, software, process or facility (ECS-SPF) development verification: PE, PO, and QA Installation and Operational verification: PE and QA Calibration, procedures, and preventive maintenance implementation: PM and PO  Project Close-out Implementation verification: PM and PE Risk Assessment Review: PEx, PO and QA Close-out Letter: PM [ 16 ]
  • 17. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Structure  Tools:  Project Origination:  Project Proposal,  Evaluation Rating Matrix  Project Initiation:  Project Charter  Proposed Schedule  Impact Assessment (GMP or Not GMP)  User Requirement Specification  Project Plan (Project Strategy)  Budget Estimate  Initial Risk Assessment (High/Medium/Low Risk) [ 17 ]
  • 18. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Structure  Tools:  Project Planning and Design:  Functional Requirement Specifications  Functional Risk Assessment  Traceability Matrix  Revised Schedule  Revised Budget  Validation Strategy  Design Specification/Qualification (DS/DQ)  Project Execution and Control  Factory Acceptance Test (FAT)  Commissioning / Site Acceptance Test (SAT) / Engineering Studies  Risk Assessment Review  Qualification / Validation Protocols  SOP’s, PM’s, and Calibration Program  Project Close-out  Traceability Matrix Review  Closing Letter [ 18 ]
  • 19. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Structure  Phases Approach:  After completion of each phase a formal Phase Review Report should be evaluated and approved by the Project Team Members.  Phase criteria should be completed before move to the next phase.  Incomplete criteria shall be justified on the Phase Review Report.  Benefits of Phases Approach:  Ensure that there is no missing elements during each phase.  Force the team members to evaluate the project goals and expectations constantly.  Keep control of the project [ 19 ]
  • 20. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Structure  How to measure Success  Align schedule with Phase Review Reports deliverables  Project design mitigate, control, and measure the identified risks  User requirements, functional requirements, and design specs were addressed and tested satisfactorily on FAT, SAT, IQ, OQ, PQ, or PV.  IOPQ and PV have been executed satisfactorily and approved.  Project has been implemented and closed as scheduled.  Project cost are within the budget requested. [ 20 ]
  • 21. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Implementation  Who, How, and When: – Change Control: • Who: PM, PE, or PO • How: Any project that affect a GMP equipment, control system, software, process or facility shall be managed under local change control process. • When: Before start with the project execution and control phase. – Schedule and Timing: • Who: PM and PE • How: Progress report and meeting should be implemented to manage the schedule and keep visibility of the project progress. Milestone shall be identified and addressed. • When: Across the entire project, typically weekly. [ 21 ]
  • 22. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Implementation  Who, How, and When: – Protocols and Verifications: • Who: Vendor, Consultant, Operation personnel, PE, or QA-Validation • How: – FAT and SAT shall be reviewed an approved by quality in order to be leverage on the IQ, OQ, and PQ. As specified on Validation Strategy. – FAT and SAT shall cover all details, configurations, functionalities, and safety requirements. – Limited IQ, OQ, and PQ can be performed based on FAT and SAT successful test. PV, as applicable, to demonstrate that the process is suitable for intended use (process is validated). • When: – FAT is performed at vendor facility. SAT performed at the site. – Qualifications / Validation: After success FAT and SAT. [ 22 ]
  • 23. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Implementation  Who, How, and When: – SOP’s and Preventive Maintenance: • Who: PO, PE, and/ or Plant Engineer • How: – Update and/or create standard operational procedure and preventive maintenance task, and include any critical instrumentation to the calibration process. – Include the changes in the Change control plan • When: – Update and development (draft) before the operational qualification. – Approved for the Performance qualification – Effectives after qualification/validation completion but before start the normal operation. [ 23 ]
  • 24. Risk-Based Approaches in GMP’s Project Life Cycles GMP Project Life Cycle – The Implementation  Who, How, and When: – Traceability Matrix, Risk Assessment Review and Closing Letter: • Who: PM, or PE • How: – Using a matrix verify that all critical requirement in URS, FRS, and DS, as applicable, were tested in one of the deliverables. – Reviewing the Risk Assessment to confirm that the risk were mitigated or controlled. – Write a memo or project plan final report summarizing the activities performance and completion. • When: – After approval of all qualification protocols final reports. [ 24 ]
  • 25. Risk-Based Approaches in GMP’s Project Life Cycles Interactive Exercise: GMP Project Life Cycle – The Application  Determine if the project is GMP or not GMP (Direct/Indirect/No Impact)  Outline a Project Life cycle  Perform a Risk Assessment  Manage Constraints  Projects: – Sampling Booth in a Warehouse – Metrology Software – Mix Tank (Reactor) – Compressed Air [ 25 ]
  • 26. Risk-Based Approaches in GMP’s Project Life Cycles Bonus Material  Risk Based Approach Project Life Cycle Phase Matrix  Phase Review Report Template [ 26 ]
  • 27. Risk-Based Approaches in GMP’s Project Life Cycles Questions and Answers ? [ 27 ]